Altro Health raises $7M to build peptide prescribing platform
Axios reports the financing exclusively, as clinician-facing peptide services draw fresh venture money following July's FDA advisory vote.
The wire
- 01Axios reports Altro Health has raised $7 million in new funding tied to its peptide business.
- 02Capital flowing into peptide prescribing and supply signals investor appetite beyond the incretin category for telehealth and compounding operators.
- 03Details on investors, use of proceeds and which peptides the company handles were not laid out in the item.
From the source
Read at axios.comExclusive: Altro Health raises $7M for peptides
